Isocitrate dehydrogenase mutation and microenvironment in gliomas: do immunotherapy approaches matter?
{{output}}
Purpose of review: Gliomas with mutations in the gene for isocitrate dehydrogenase (IDH) display a unique immune microenvironment that is distinct from IDH-wildtype gliomas. This unique immune microenvironment is shaped by 2-hydr... ...
